Opko Health Inc.

News & Events

Press Releases

In The Media

1. OPKO Health's ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

   GlobeNewswire JUN 9, 2025 8:00 AM EDT
   Will provide expertise across ModeX’s portfolio of next generation multispecific antibodie...
   READ ARTICLE

2. OPKO Health to Participate in Two Upcoming Investor Conferences

   GlobeNewswire MAY 15, 2025 8:00 AM EDT
   MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that ...
   READ ARTICLE

3. OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

   GlobeNewswire APR 30, 2025 4:05 PM EDT
   MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business hi...
   READ ARTICLE

4. OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025

   GlobeNewswire APR 17, 2025 8:00 AM EDT
   MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report ope...
   READ ARTICLE

5. NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program

   PR Newswire APR 11, 2025 4:05 PM EDT
   NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program ...
   READ ARTICLE

6. OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

   GlobeNewswire APR 4, 2025 8:00 AM EDT
   MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) tod...
   READ ARTICLE

7. OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

   GlobeNewswire MAR 17, 2025 8:00 AM EDT
   MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Enter...
   READ ARTICLE

8. Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

   PR Newswire MAR 11, 2025 7:00 AM EDT
   Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and R...
   READ ARTICLE

9. OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

   GlobeNewswire FEB 27, 2025 4:10 PM EST
   MIAMI, Feb. 27, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business hig...
   READ ARTICLE

10. OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025

    GlobeNewswire FEB 13, 2025 4:05 PM EST
    MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report oper...
    READ ARTICLE